Please assess the completion status of the following clinical trial:

Trial Title: StrataGraft® Skin Tissue Expanded Access at Specific Study Sites ( StrataCAT )

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE3
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~To be considered for inclusion, a participant must:~* Provide written informed consent~* Have enough healthy skin to reserve as donor site(s), in case autografting becomes necessary~* Have protocol-defined thermal burn(s) on the torso, upper extremities and lower extremities:~  1. that are the right size for treatment areas,~ 2. with intact dermal elements for which excision and autografting are clinically indicated, and~ 3. have not been previously excised and grafted.~Exclusion Criteria:~A participant must be excluded from participation if he/she:~* Is pregnant, a prisoner, or expected to live less than 3 months~* Has any other condition that, per protocol or in the opinion of the investigator, may compromise the participant's safety or the study objectives~* Has participated in an investigational study within 90 days before enrollment

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- StrataGraft (Type: EXPERIMENTAL): On Day 1, participants received a single application of up to 1:1 meshed StrataGraft skin tissue on up to 3 DPT wound(s) totaling no more than approximately 2000 square centimeters (cm\^2) in area.

Based on this trial design, predict the completion outcome and termination type (if applicable).